JP5143841B2 - 高度な薬物開発及び製造 - Google Patents

高度な薬物開発及び製造 Download PDF

Info

Publication number
JP5143841B2
JP5143841B2 JP2009532446A JP2009532446A JP5143841B2 JP 5143841 B2 JP5143841 B2 JP 5143841B2 JP 2009532446 A JP2009532446 A JP 2009532446A JP 2009532446 A JP2009532446 A JP 2009532446A JP 5143841 B2 JP5143841 B2 JP 5143841B2
Authority
JP
Japan
Prior art keywords
acid
receptor
amino
methyl
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2009532446A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010509566A (ja
Inventor
バーンボーム，エバ・アール
コピシユ，アンドリユー・テイー
ボールドウイン，シヤロン・エム
ワーナー，ベンジヤミン・ピー
マクレスキー，マーク・テイー
バーガー，ジエニフアー・エイ
スチユアート，ジエフリー・ジエイ
ハリス，マイケル・エヌ
バレル，アンソニー・ケイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Los Alamos National Security LLC
Original Assignee
Los Alamos National Security LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Los Alamos National Security LLC filed Critical Los Alamos National Security LLC
Publication of JP2010509566A publication Critical patent/JP2010509566A/ja
Application granted granted Critical
Publication of JP5143841B2 publication Critical patent/JP5143841B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21K—TECHNIQUES FOR HANDLING PARTICLES OR IONISING RADIATION NOT OTHERWISE PROVIDED FOR; IRRADIATION DEVICES; GAMMA RAY OR X-RAY MICROSCOPES
    • G21K7/00—Gamma- or X-ray microscopes
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21K—TECHNIQUES FOR HANDLING PARTICLES OR IONISING RADIATION NOT OTHERWISE PROVIDED FOR; IRRADIATION DEVICES; GAMMA RAY OR X-RAY MICROSCOPES
    • G21K2207/00—Particular details of imaging devices or methods using ionizing electromagnetic radiation such as X-rays or gamma rays

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of Radiation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
JP2009532446A 2006-10-10 2007-10-10 高度な薬物開発及び製造 Active JP5143841B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85059406P 2006-10-10 2006-10-10
US60/850,594 2006-10-10
PCT/US2007/021888 WO2008127291A2 (en) 2006-10-10 2007-10-10 Advanced drug development and manufacturing

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012122988A Division JP2012230109A (ja) 2006-10-10 2012-05-30 高度な薬物開発及び製造

Publications (2)

Publication Number Publication Date
JP2010509566A JP2010509566A (ja) 2010-03-25
JP5143841B2 true JP5143841B2 (ja) 2013-02-13

Family

ID=39864504

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009532446A Active JP5143841B2 (ja) 2006-10-10 2007-10-10 高度な薬物開発及び製造
JP2012122988A Pending JP2012230109A (ja) 2006-10-10 2012-05-30 高度な薬物開発及び製造
JP2014123249A Active JP5913441B2 (ja) 2006-10-10 2014-06-16 高度な薬物開発及び製造

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2012122988A Pending JP2012230109A (ja) 2006-10-10 2012-05-30 高度な薬物開発及び製造
JP2014123249A Active JP5913441B2 (ja) 2006-10-10 2014-06-16 高度な薬物開発及び製造

Country Status (4)

Country Link
EP (2) EP2084519B1 (enExample)
JP (3) JP5143841B2 (enExample)
DK (1) DK2084519T3 (enExample)
WO (1) WO2008127291A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9157875B2 (en) 2001-05-16 2015-10-13 Benjamin P. Warner Drug development and manufacturing
US10877035B2 (en) 2001-05-16 2020-12-29 Icagen, Llc Advanced drug development and manufacturing

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170123724A (ko) 2006-03-28 2017-11-08 자블린 파머슈티칼스 인코포레이티드 저 투여량의 디클로페낙 및 베타-사이클로덱스트린 제형
US8637528B2 (en) 2007-03-27 2014-01-28 Omeros Corporation Use of PDE7 inhibitors for the treatment of movement disorders
BR112012012406B1 (pt) 2009-11-23 2021-11-16 Cubist Pharmaceuticals Llc Composições farmacêuticas sólidas de daptomicina, seu produto farmacêutico e seus métodos de fabricação
CN101865845A (zh) * 2010-06-11 2010-10-20 宁波市疾病预防控制中心 一种简便的敌鼠和氯敌鼠测定的荧光分析方法
CN101897719B (zh) * 2010-08-04 2012-01-25 中国人民解放军第三军医大学 一种用于治疗烟雾吸入性肺损伤的药物组合物
JP5926484B2 (ja) 2010-11-18 2016-05-25 株式会社セルシード グリコサミノグリカンの新規な分析方法
JP6596334B2 (ja) * 2012-07-10 2019-10-23 ビーエーエスエフ ソシエタス・ヨーロピア 硫酸コバルト水溶液の製造方法
JP5437525B1 (ja) 2012-12-28 2014-03-12 株式会社ナード研究所 チロシン誘導体およびチロシン誘導体の製造方法
US20140243220A1 (en) * 2013-02-25 2014-08-28 J. Craig Venter Institute Metaproteomic Method to Identify Secreted Pattern Recognition Molecules and Adhesive Antimicrobial Factors for Detection of Microbial Agents Eliciting Inflammation in the Human Host
KR101651330B1 (ko) * 2014-07-28 2016-08-25 가톨릭대학교 산학협력단 세포투과성이 우수한 ｔａｔ－ａ２０ 융합단백질의 제조방법 및 이의 용도
RU2582960C1 (ru) * 2014-10-17 2016-04-27 Федеральное Государственное Бюджетное Образовательное Учреждение Высшего Профессионального Образования "Саратовский Государственный Университет Имени Н.Г. Чернышевского" Способ флуориметрического определения флуниксина
CN104865336B (zh) * 2015-06-09 2017-04-12 成都百裕制药股份有限公司 高效液相色谱检测阿瑞匹坦中有关物质的方法
WO2017096049A1 (en) 2015-12-03 2017-06-08 The University Of North Carolina At Pembroke Materials for cathepsin b enhancement and methods of use
CA3031091A1 (en) * 2016-07-18 2018-01-25 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for promoting neurogenesis and inhibiting nerve cell death
HUE046449T2 (hu) 2016-09-13 2020-03-30 Allergan Inc Stabilizált, nem fehérje eredetû, clostridiális toxin készítmények
KR101919220B1 (ko) 2017-01-24 2018-11-16 경북대학교 산학협력단 피리독살 5-포스페이트에 대한 친화도가 향상된 라이신 디카르복실라제 변이효소 및 이를 이용한 카다베린의 생산방법
CN107037154A (zh) * 2017-04-26 2017-08-11 苏州海科医药技术有限公司 人血浆中泮托拉唑的手性lc‑ms/ms高通量检测方法
CN109387630A (zh) * 2017-08-14 2019-02-26 杭州源昶医药科技有限公司 用于预测吉西他滨药物敏感性的生物标记物及其用途
CN108051513B (zh) * 2017-11-27 2020-09-29 重庆华邦制药有限公司 Hplc法分离测定度他雄胺起始原料sm2及其相关杂质的方法
CN113325109A (zh) * 2017-12-29 2021-08-31 宁夏希望田野生物农业科技有限公司 一种菌渣中林可霉素残留量的检测方法
CN108669447A (zh) * 2018-05-03 2018-10-19 四川东方主食产业技术研究院 一种非油炸杂粮方便面及其生产方法
CN108587998B (zh) * 2018-05-17 2021-05-18 浙江大学 一种外泌体、外泌体的制备方法及其在制备皮肤浅表性肿瘤的药物中的应用
CN108982681A (zh) * 2018-05-25 2018-12-11 蒙牛乳业泰安有限责任公司 一种牛乳中林可霉素的检测方法
WO2020059401A1 (ja) * 2018-09-21 2020-03-26 小嶋　良種 生体液の検査方法
CN109187798A (zh) * 2018-10-09 2019-01-11 山西省食品药品检验所(山西省药品包装材料监测中心) 检测去甲基卡波地那非、丙氧基艾地那非、n-乙基他达拉非和羟丙基去甲基他达拉非方法
CN109380304B (zh) * 2018-11-28 2020-12-01 吉林大学 一种抗植物腐烂病的氧化物纳米材料、制备方法及其应用
CN109444294B (zh) * 2018-12-27 2021-06-22 苏州莱奥生物技术有限公司 一种分离利奈唑胺和其手性异构体的高效液相色谱方法
CN109490444B (zh) * 2018-12-28 2021-06-01 重庆华邦制药有限公司 一种hplc法分离测定度他雄胺原料药及制剂中降解杂质的方法
CN109799307A (zh) * 2018-12-31 2019-05-24 辰欣药业股份有限公司 一种阿德福韦酯片的有关物质检测方法
TWI852986B (zh) * 2019-02-08 2024-08-21 法商優若亞琵法國公司 微生物之生物技術最佳化
CN109810991B (zh) * 2019-03-02 2021-11-12 昆明理工大学 二氢蝶酸合酶基因folP的用途
CN110075322B (zh) * 2019-05-20 2021-07-06 复旦大学附属妇产科医院 一种靶向GnRH受体的近红外荧光成像探针及其制备方法与应用
CN110146621B (zh) * 2019-06-13 2022-01-07 国药集团致君（深圳）制药有限公司 头孢类抗生素药物中聚合物的含量测定方法
US20220339184A1 (en) * 2019-09-27 2022-10-27 The Rockefeller University Compositions and methods to treat metastatic gastrointestinal cancer
CN110628737B (zh) * 2019-10-14 2022-06-07 南京农业大学 一个调控黄瓜矮化性状相关基因及其应用
CN110734899B (zh) * 2019-10-31 2021-06-18 江南大学 一种酶活提高的蔗糖磷酸化酶突变体及其构建方法和应用
CN113493756B (zh) * 2020-04-03 2025-07-29 弈柯莱生物科技(集团)股份有限公司 一种基因工程菌及其应用
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
CN113686977B (zh) * 2020-05-18 2023-08-08 武汉中博绿亚生物科技有限公司 复方芬苯达唑制剂中有关物质的测定方法
CN111665309A (zh) * 2020-07-21 2020-09-15 南京品生医疗科技有限公司 一种检测血清中核苷类抗病毒药物的试剂盒及其应用
CN111830162A (zh) * 2020-07-21 2020-10-27 南京品生医学检验实验室有限公司 一种检测血清中核苷类抗病毒药物浓度的方法
CN112305134B (zh) * 2020-11-05 2022-07-12 北京和合医学诊断技术股份有限公司 曲唑酮的检测方法
CN112394124A (zh) * 2020-11-05 2021-02-23 广州白云山医药集团股份有限公司白云山制药总厂 一种血浆中西地那非、n-去甲基西地那非及n1,n4-去二甲基西地那非含量分析方法
CN112461961A (zh) * 2020-11-17 2021-03-09 湖南泰新医药科技有限公司 测定人血浆中咪唑斯汀浓度的方法
CN113337546B (zh) * 2021-06-04 2023-09-12 上海启讯医药科技有限公司 一种(s)-1，2，4-丁三醇的制备方法
CN113607842B (zh) * 2021-07-30 2023-07-21 江西省药品检验检测研究院 一种乳酸左氧氟沙星中乳酸的鉴别与含量测定方法
CN116110513B (zh) * 2021-11-09 2025-08-15 中国石油化工股份有限公司 一种三嗪类脱硫剂的分子设计方法和用途
CN114324663B (zh) * 2021-12-31 2023-08-15 北京金城泰尔制药有限公司 检测氯诺昔康有关物质的方法
JP2023140319A (ja) 2022-03-22 2023-10-04 アッヴィ・インコーポレイテッド ブルトン型チロシンキナーゼを分解するためのピリミジン
CN115006386B (zh) * 2022-03-28 2024-03-26 中国人民解放军海军军医大学 硝呋齐特在制备抗蜱传脑炎病毒西尼罗病毒黄热病毒和基孔肯雅热病毒感染药物中的应用
CN117159557B (zh) * 2022-05-26 2025-11-28 天津国际生物医药联合研究院 吡啶硫酮锌在制备治疗日本脑炎病毒感染药物中的应用
CN117186177B (zh) * 2022-05-31 2024-08-23 中国农业大学 一种具有降尿酸活性的鸭血球蛋白肽及其制备方法
CN115160408B (zh) * 2022-06-29 2025-04-22 辽宁天增祥生物科技有限公司 降压肽或中国蛤蜊降压肽提取物及其应用
CN115282640B (zh) * 2022-07-05 2023-07-04 河北大学 一种分子印迹固相微萃取纤维涂层及其制备方法与应用
CN115181758A (zh) * 2022-09-07 2022-10-14 中国科学院天津工业生物技术研究所 一种固定化酶催化合成活性维生素ｄ的方法
CN115718149B (zh) * 2022-11-07 2025-05-02 中北大学 一种1-甲基吡唑的纯度分析方法
CN116024260B (zh) * 2022-12-16 2025-06-13 山东农业大学 拟南芥AteIF4E基因在提高植物氮素利用效率和产量中的用途
US12396981B2 (en) 2023-03-09 2025-08-26 William Shulman Methods of using DMT
CN116747321B (zh) * 2023-06-14 2025-09-05 厦门君德医药科技有限公司 一种接枝改性的介孔二氧化硅及其制备方法和应用
CN116622514B (zh) * 2023-07-21 2023-10-20 南京师范大学 提高微生物菌体和/或微生物油脂中多不饱和脂肪酸含量的调控方法及应用
CN117815401B (zh) * 2024-03-06 2024-05-31 四川省医学科学院·四川省人民医院 联合光热效应和自噬抑制的纳米调节剂及制备方法和应用
CN118937545B (zh) * 2024-10-10 2025-01-28 成都普什制药有限公司 一种莫西沙星及其杂质的分离检测方法
CN119198705B (zh) * 2024-11-28 2025-04-22 吉林敖东药业集团延吉股份有限公司 一种注射用转移因子中核糖含量的测定方法和应用
CN120577449B (zh) * 2025-07-30 2025-10-03 浙江省中医院、浙江中医药大学附属第一医院（浙江省东方医院） 一种乌梅止利颗粒的质量检测方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61152700A (ja) * 1984-12-26 1986-07-11 Susumu Kogyo Kk タンパク質固定用膜担体およびその製造法
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5547839A (en) 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
EP0815437A1 (en) * 1996-01-12 1998-01-07 Koninklijke Philips Electronics N.V. X-ray analysis apparatus including a rotatable primary collimator
JPH10182693A (ja) * 1996-11-05 1998-07-07 Seibutsu Bunshi Kogaku Kenkyusho:Kk 分子の配向制御方法
US6344330B1 (en) 1998-03-27 2002-02-05 The Regents Of The University Of California Pharmacophore recombination for the identification of small molecule drug lead compounds
US6054047A (en) 1998-03-27 2000-04-25 Synsorb Biotech, Inc. Apparatus for screening compound libraries
US6406921B1 (en) * 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
US6147344A (en) 1998-10-15 2000-11-14 Neogenesis, Inc Method for identifying compounds in a chemical mixture
JP3396460B2 (ja) * 2000-04-10 2003-04-14 理学電機工業株式会社 蛍光ｘ線分析装置及びそれに使用するｘ線検出器
US7365118B2 (en) 2003-07-08 2008-04-29 Los Alamos National Security, Llc Polymer-assisted deposition of films
US6719147B2 (en) * 2001-04-27 2004-04-13 The University Of Delaware Supported mesoporous carbon ultrafiltration membrane and process for making the same
US9157875B2 (en) * 2001-05-16 2015-10-13 Benjamin P. Warner Drug development and manufacturing
US7858385B2 (en) * 2001-05-16 2010-12-28 Los Alamos National Security, Llc Method for detecting binding events using micro-X-ray fluorescence spectrometry
US6858148B2 (en) * 2003-07-16 2005-02-22 The Regents Of The University Of California Method and apparatus for detecting chemical binding
US20040017884A1 (en) * 2002-07-25 2004-01-29 Havrilla George J. Flow method and apparatus for screening chemicals using micro x-ray fluorescence
WO2003017167A1 (en) * 2001-07-25 2003-02-27 Mydatavault, Inc. Secure records storage and retrieval system and method
JP2005528582A (ja) * 2001-09-07 2005-09-22 コーニング インコーポレイテッド ハイスループット分析のためのマイクロカラム・プラットフォームに基づくアレイ
CA2431076A1 (en) * 2002-05-29 2003-11-29 F. Mervyn Cavers Access system, device and method
JP3823316B2 (ja) * 2002-06-21 2006-09-20 横河電機株式会社 ネットワーク対応形測定装置
US6844543B2 (en) * 2002-07-03 2005-01-18 The Regents Of The University Of California Quantitation of absorbed or deposited materials on a substrate that measures energy deposition
US7334130B2 (en) * 2002-07-19 2008-02-19 Bowers Charles R Method and apparatus for managing confidential information
US7661127B2 (en) * 2002-11-12 2010-02-09 Millipore Corporation Instrument access control system
JP4045999B2 (ja) * 2003-04-11 2008-02-13 株式会社島津製作所 機器分析用データ管理装置
US7276011B2 (en) 2003-08-18 2007-10-02 Toyota Jidosha Kabushiki Kaisha Automatic transmission
US6958480B1 (en) 2004-06-25 2005-10-25 The Regents Of The University Of California Sample desorption/ionization from mesoporous silica
JP2006048519A (ja) * 2004-08-06 2006-02-16 Sony Corp データ送信プログラム，パスワード発行システム及びデータ処理サービスシステム

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9157875B2 (en) 2001-05-16 2015-10-13 Benjamin P. Warner Drug development and manufacturing
US10877035B2 (en) 2001-05-16 2020-12-29 Icagen, Llc Advanced drug development and manufacturing

Also Published As

Publication number Publication date
WO2008127291A3 (en) 2009-05-14
JP2012230109A (ja) 2012-11-22
EP2084519A2 (en) 2009-08-05
EP2511844A3 (en) 2013-03-27
JP2014221047A (ja) 2014-11-27
JP2010509566A (ja) 2010-03-25
HK1177280A1 (en) 2013-08-16
JP5913441B2 (ja) 2016-04-27
WO2008127291A2 (en) 2008-10-23
EP2511844A2 (en) 2012-10-17
DK2084519T3 (da) 2012-08-20
EP2084519A4 (en) 2010-02-24
EP2511844B1 (en) 2015-08-12
EP2084519B1 (en) 2012-08-01

Similar Documents

Publication Publication Date Title
JP5913441B2 (ja) 高度な薬物開発及び製造
US10877035B2 (en) Advanced drug development and manufacturing
EP3681504B1 (en) Methods of detection using x-ray fluorescence
Cunha et al. Parallel modification of adenosine extracellular metabolism and modulatory action in the hippocampus of aged rats
TWI335334B (en) Methods and compositions for treating hepatitis c virus
DE60105424T2 (de) Methoden zur behandlung von delta hepatitis virus infektionen mit beta-l-2' deoxy-nucleosiden
Aghamirza Moghim Aliabadi et al. COVID‐19: A systematic review and update on prevention, diagnosis, and treatment
US12195753B2 (en) Nucleic acid and other compositions and methods for the modulation of cell membranes
US11814681B2 (en) Method for predicting a subjects response to SLC modulator therapy
JP2016515383A (ja) 樹状細胞応答遺伝子発現、組成物およびその使用方法
Jia et al. Copper (II)–mediated sliver nanoclusters as a fluorescent platform for highly sensitive detection of alendronate sodium
Mitsuyama et al. Neutrophil-induced endothelial cell damage: inhibition by a 14-membered ring macrolide through the action of nitric oxide
WO2020219423A1 (en) Combination therapies including inhibitors of dihydroorotate dehydrogenase
KR101902656B1 (ko) 은 나노입자를 유효성분으로 포함하는 항암 및 항암 보조제 조성물
HK1177280B (en) X-ray microscope
Bottcher et al. Liposome triggered content release through molecular recognition of inositol trisphosphate
Fyrberg et al. Optimization and evaluation of electroporation delivery of siRNA in the human leukemic CEM cell line
US20200115408A1 (en) Trehalose analogues
WO2020123246A1 (en) Therapeutic methods using multiple agents that achieve the same phenotypic response
Oxford Approaches towards rational antiviral chemotherapy
Dittrich et al. Metabolic changes during cardiac regeneration in the axolotl
WO2024192141A1 (en) Treatment of cancers having a drug-resistant mesenchymal cell state
Kuz’min et al. QSAR analysis of anti-coxsackievirus B3 nancy activity of 2-amino-3-nitropyrazole [1, 5-α] pyrimidines by means of simplex approach
Park et al. Identification and biochemical studies on novel non-nucleoside inhibitors of the enzyme adenosine kinase
Strašilová Vazebné vlastnosti enzymů purinnukleosidfosforylasa a thymidinfosforylasa

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20101007

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120131

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20120202

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120424

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120502

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120530

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120807

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120919

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20121023

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20121121

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20151130

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 5143841

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250